(LOS ANGELES) — Pfizer and Moderna are expanding the size of their COVID-19 vaccine studies in children ages 5 to 11, according to a new report. The decision, which came after a push from the... Read More.
(NEW YORK) -- Pfizer and BioNTech have released initial data from a study on booster shots for their COVID-19 vaccine, saying a third dose delivered about six months after the second shot has shown... Read More.
(NEW YORK) -- Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical company announced Tuesday. Based on safety, efficacy and tolerability data from Pfizer's Phase... Read More.
Harrisburg, PA - The Department of Health encouraged all COVID-19 vaccine providers to start vaccinating anyone age 12 and over with the Pfizer vaccine as recommended by the U.S. Food and Drug Administration (FDA)... Read More.
(NEW YORK) -- COVID-19 vaccine eligibility has now been widened for children ages 12 and up. The U.S. Food and Drug Administration (FDA) on Monday authorized the Pfizer vaccine for children ages 12 to 15,... Read More.
(NEW YORK) -- The Pfizer vaccine has been authorized for children ages 12 and up, widening the U.S. population that will be protected against the virus and bolstering chances for a safe return to... Read More.
(NEW YORK) -- Pfizer and BioNTech will be providing COVID-19 vaccines to Olympic athletes participating in the summer games in Tokyo. The pharmaceutical companies signed a memorandum of understanding with the International Olympic Committee on... Read More.
(NEW YORK) -- Pfizer and partner BioNtech announced they are starting the process to seek full Food and Drug Administration approval in the U.S. for their COVID-19 vaccine. Since December, their vaccine has been distributed... Read More.
(NEW YORK) -- The first real-world study pitting COVID-19 variants against the Pfizer vaccine showed that the variant first detected in South Africa may be able to evade some vaccine protection, new research conducted... Read More.